BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 27611086)

  • 1. Single-cell analysis reveals androgen receptor regulates the ER-to-Golgi trafficking pathway with CREB3L2 to drive prostate cancer progression.
    Hu L; Chen X; Narwade N; Lim MGL; Chen Z; Tennakoon C; Guan P; Chan UI; Zhao Z; Deng M; Xu X; Sung WK; Cheung E
    Oncogene; 2021 Nov; 40(47):6479-6493. PubMed ID: 34611310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the Golgi apparatus in disease (Review).
    Liu J; Huang Y; Li T; Jiang Z; Zeng L; Hu Z
    Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33537825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gfi-1 promotes proliferation of human cervical carcinoma via targeting of FBW7 ubiquitin ligase expression.
    Cai H; Zhang F; Li Z
    Cancer Manag Res; 2018; 10():2849-2857. PubMed ID: 30197537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse Role of SNARE Protein GS28 in Vesicle Trafficking and Diseases.
    Li M; Liu R; Zhao Y; Liu P
    Curr Protein Pept Sci; 2023; 24(4):288-295. PubMed ID: 36924089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Worse Prognosis in Cervical Cancers.
    Cho U; Kim HM; Park HS; Kwon OJ; Lee A; Jeong SW
    PLoS One; 2016; 11(9):e0162623. PubMed ID: 27611086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Prognosis in Colorectal Cancers.
    Lee SH; Yoo HJ; Rim DE; Cui Y; Lee A; Jung ES; Oh ST; Kim JG; Kwon OJ; Kim SY; Jeong SW
    Int J Med Sci; 2017; 14(6):515-522. PubMed ID: 28638266
    [No Abstract]   [Full Text] [Related]  

  • 7. Golgi-SNARE GS28 potentiates cisplatin-induced apoptosis by forming GS28-MDM2-p53 complexes and by preventing the ubiquitination and degradation of p53.
    Sun NK; Huang SL; Chien KY; Chao CC
    Biochem J; 2012 Jun; 444(2):303-14. PubMed ID: 22397410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
    Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 in surgically treated and pathologically staged cervical cancer: correlation with local tumor progression, but not with lymphatic spread.
    Horn LC; Fischer U; Hänel C; Kuhn H; Raptis G; Bilek K
    Pathol Res Pract; 2001; 197(9):605-9. PubMed ID: 11569924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
    Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
    Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of p53 expression for patients with cervical cancer: a meta analysis.
    Zhou R; Wei C; Liu J; Luo Y; Tang W
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():210-213. PubMed ID: 26595307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of SNARE proteins in tumourigenesis and their potential as targets for novel anti-cancer therapeutics.
    Meng J; Wang J
    Biochim Biophys Acta; 2015 Aug; 1856(1):1-12. PubMed ID: 25956199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the SNARE protein syntaxin 1 inhibits glioblastoma tumor growth.
    Ulloa F; Gonzàlez-Juncà A; Meffre D; Barrecheguren PJ; Martínez-Mármol R; Pazos I; Olivé N; Cotrufo T; Seoane J; Soriano E
    PLoS One; 2015; 10(3):e0119707. PubMed ID: 25803850
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.